中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
罗拉克托尔 |
Ronactolol |
90895-85-5 |
C20H26N2O4 |
|
罗托沙敏 |
(S)-carbinoxamine |
5560-77-0 |
C16H19ClN2O |
|
罗尼贝特 |
Ronifibrate |
42597-57-9 |
C19H20ClNO5 |
|
罗尼帕米 |
Ronipamil |
85247-77-4 |
C32H48N2 |
|
罗喹美克 |
roquinimex |
84088-42-6 |
C18H16N2O3 |
|
罗哌卡因标准品004 |
N-(2,4-dimethylphenyl)picolinamide |
352637-51-5 |
C14H14N2O |
|
罗哌卡因杂质5 |
N-propyl-2,6-dimethylaniline |
826-99-3 |
C11H17N |
|
罗哌卡因杂质 |
Nicotinsaeure-(2,6-dimethyl-anilid) |
84951-65-5 |
C14H14N2O |
|
罗匹尼罗中间体 |
2-methyl-3-nitro-N,N-di-n-propyl phenylethylammonium oxalate |
915376-75-9 |
C2H2O4*C15H24N2O2 |
|
罗匹嗪 |
(4-benzhydryl-piperazin-1-yl)-(6-methyl-pyridin-2-ylmethylene)-amine |
3601-19-2 |
C24H26N4 |
|
缺甲心可定 |
Fendiline |
13042-18-7 |
C23H25N |
|
缬沙坦酰胺苄酯 |
(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyric acid benzyl ester |
137864-22-3 |
C31H34N2O3 |
|
缬沙坦烃化物 |
N-[(2'-cyanobiphenyl-4-yl)-methyl]-(L)-valine methyl ester |
137863-89-9 |
C20H22N2O2 |
|
缬沙坦杂质8 |
5-(4'-(azidomethyl)-[1,1'-biphenyl]-2-yl)-1H-1,2,3,4-tetrazole |
152708-24-2 |
C14H11N7 |
|
绿麦隆 |
N-(3-chloro-4-methylphenyl)-N,N-dimethylurea |
15545-48-9 |
C10H13ClN2O |
|
绿谷隆 |
1-(4-chlorophenyl)-3-methyl-3-methoxyurea |
1746-81-2 |
C9H11ClN2O2 |
|
维罗司他 |
verubecestat |
1286770-55-5 |
C17H17F2N5O3S |
|
维米醇 |
1-(α-N-o-Chlorbenzyl-pyrryl)-2-di-se.-butylamino-ethanol |
21363-18-8 |
C21H31ClN2O |
|
维生素U |
N-(2,2,2-Trichlor-1-phenylcarbamoyloxy-aethoxy)-morpholin |
3293-12-7 |
C13H15Cl3N2O4 |
|
维生素E醋酸酯 |
STREPTOZOTOCIN |
1888-36-4 |
C18H18N4O6S |
|
维曲布汀 |
[1-(3,4-dimethoxy-phenyl)-4-phenyl-butyl]-dimethyl-amine |
3735-45-3 |
C20H27NO2 |
|
维拉烟肼 |
(E)-N’-(3',4'-dimethoxybenzylidene)isonicotinohydrazide |
93-47-0 |
C15H15N3O3 |
|
维拉必利 |
N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamide hydrochloride |
66644-83-5 |
C17H25N3O5S*ClH |
|
维拉必利 |
Veralipride |
66644-81-3 |
C17H25N3O5S |
|
维拉帕米相关物D |
5,5'-((2-(3,4-Dimethoxyphenyl)ethyl)imino)bis(2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile)hydrochloride |
190850-50-1 |
C42H58ClN3O6 |
|
维拉帕米杂质O |
Desisopropyl N-propyl verapamil |
959011-16-6 |
C27H38N2O4 |
|
维拉帕米杂质N(EP) |
5,5'-(Methylimino)bis(2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile) |
2086274-75-9 |
C33H47N3O4 |
|
维拉帕米杂质 |
3-[N-methyl-N-(2-{3,4-dimethoxy-phenyl}-ethyl)amino]-propanol |
85175-54-8 |
C14H23NO3 |
|
维拉帕米杂质 |
D 703 |
67018-80-8 |
C26H36N2O4 |
|
维拉帕米 |
(2S)-(-)-gallopamil |
36622-40-9 |
C28H40N2O5 |
|
维拉帕米 |
Verapamil |
52-53-9 |
C27H38N2O4 |
|
维多氟拉迪莫 |
2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid |
717824-30-1 |
C20H18FNO4 |
|
维塞诺钠盐 |
Vercirnon sodium |
886214-18-2 |
C22H20ClN2NaO4S |
|
维兰特罗杂质3 |
FE6Njg54F9 |
503070-62-0 |
C23H31Cl2NO5 |
|
维兰特罗杂质 |
[({2-[(6-bromohexyl)oxy]ethyl}oxy)methyl]benzene |
503068-31-3 |
C15H23BrO2 |
|
维兰特罗三苯乙酸盐 |
vilanterol trifenatate |
503070-58-4 |
C20H16O2*C24H33Cl2NO5 |
|
维兰特罗 |
vilanterol |
503068-34-6 |
C24H33Cl2NO5 |
|
绕丹酸铵盐 |
Ammonium rhodanilate |
10380-20-8 |
C16H14CrN6S4*H4N |
|
结晶紫阳离子 |
{4-[Bis-(4-dimethylamino-phenyl)-methylene]-cyclohexa-2,5-dienylidene}-dimethyl-ammonium |
14426-25-6 |
C25H30N3 |
|
细胞色素P45014a-脱甲基酶抑制剂1J |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-methylbenzyl)-amino]-2-propanol |
1155361-08-2 |
C22H24F2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1I |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(4-bromobenzyl)-amino]-2-propanol |
1155361-07-1 |
C21H21BrF2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1H |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-bromobenzyl)-amino]-2-propanol |
1155361-06-0 |
C21H21BrF2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1E |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-chlorobenzyl)-amino]-2-propanol |
1155361-03-7 |
C21H21ClF2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1D |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(4-fluorobenzyl)-amino]-2-propanol |
1155361-02-6 |
C21H21F3N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1C |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(3-fluorobenzyl)-amino]-2-propanol |
1155361-01-5 |
C21H21F3N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1B |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-fluorobenzyl)-amino]-2-propanol |
1155361-00-4 |
C21H21F3N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1A |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-benzyl-amino]-2-propanol |
1155360-99-8 |
C21H22F2N4O |
|
细叶青蒌藤素 |
(+)-crotepoxide |
20421-13-0 |
C18H18O8 |
|
组胺三氟甲基-甲苯胺 |
HTMT |
103827-16-3 |
C19H25F3N4O |
|
组织蛋白酶D抑制剂 |
1-(3-Methylphenyl)butan-2-amine |
147702-27-0 |
C11H17N |
|